277 related articles for article (PubMed ID: 21269443)
21. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
[TBL] [Abstract][Full Text] [Related]
22. Early switching strategies in antidepressant non-responders: current evidence and future research directions.
Kudlow PA; McIntyre RS; Lam RW
CNS Drugs; 2014 Jul; 28(7):601-9. PubMed ID: 24831418
[TBL] [Abstract][Full Text] [Related]
23. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
24. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder.
Chen JCC; Sumner RL; Krishnamurthy Naga V; Hoeh N; Ayeni HA; Singh V; Sundram F; Campbell D; Muthukumaraswamy S
Trials; 2020 Feb; 21(1):157. PubMed ID: 32041658
[TBL] [Abstract][Full Text] [Related]
25. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.
Więdłocha M; Marcinowicz P; Krupa R; Janoska-Jaździk M; Janus M; Dębowska W; Mosiołek A; Waszkiewicz N; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):217-226. PubMed ID: 28445690
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory biomarkers as differential predictors of antidepressant response.
Hashimoto K
Int J Mol Sci; 2015 Apr; 16(4):7796-801. PubMed ID: 25856677
[TBL] [Abstract][Full Text] [Related]
27. tiRNA-Gly-GCC-001 in major depressive disorder: Promising diagnostic and therapeutic biomarker.
Tian H; Gao S; Xu M; Yang M; Shen M; Liu J; Li G; Zhuang D; Hu Z; Wang C
Br J Pharmacol; 2024 Jul; 181(13):1952-1972. PubMed ID: 38439581
[TBL] [Abstract][Full Text] [Related]
28. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
29. Plasma fibrinogen: now also an antidepressant response marker?
Martins-de-Souza D; Maccarrone G; Ising M; Kloiber S; Lucae S; Holsboer F; Turck CW
Transl Psychiatry; 2014 Jan; 4(1):e352. PubMed ID: 24473443
[TBL] [Abstract][Full Text] [Related]
30. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
[TBL] [Abstract][Full Text] [Related]
31. The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients.
Chang HH; Chi MH; Lee IH; Tsai HC; Gean PW; Yang YK; Lu RB; Chen PS
J Affect Disord; 2013 Sep; 150(2):295-9. PubMed ID: 23664565
[TBL] [Abstract][Full Text] [Related]
32. The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial.
Kingslake J; Dias R; Dawson GR; Simon J; Goodwin GM; Harmer CJ; Morriss R; Brown S; Guo B; Dourish CT; Ruhé HG; Lever AG; Veltman DJ; van Schaik A; Deckert J; Reif A; Stäblein M; Menke A; Gorwood P; Voegeli G; Pérez V; Browning M
Trials; 2017 Nov; 18(1):558. PubMed ID: 29169399
[TBL] [Abstract][Full Text] [Related]
33. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
[TBL] [Abstract][Full Text] [Related]
34. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
36. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
37. Prediction of the time-course pattern of remission in depression by using clinical, neuropsychological, and genetic variables.
Gudayol-Ferré E; Guàrdia-Olmos J; Peró-Cebollero M; Herrera-Guzmán I; Camarena B; Cortés-Penagos C; Herrera-Abarca JE; Martínez-Medina P
J Affect Disord; 2013 Sep; 150(3):1082-90. PubMed ID: 23787408
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
39. The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder.
Liu W; Zhang F; Zheng Y; He S; Zhang T; Guo Q; Xu H; Chen H; Liu C; Yu S; Jiang K; Li H; Li G; Wang X; Liu X
Neurosci Lett; 2021 Oct; 763():136184. PubMed ID: 34418506
[TBL] [Abstract][Full Text] [Related]
40. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
Fiori LM; Lopez JP; Richard-Devantoy S; Berlim M; Chachamovich E; Jollant F; Foster J; Rotzinger S; Kennedy SH; Turecki G
Int J Neuropsychopharmacol; 2017 Aug; 20(8):619-623. PubMed ID: 28520926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]